ArticleFrontiers in endocrinology2026
C-reactive protein-to-albumin ratio improves prediction of 6-month major adverse limb events in diabetic foot ulcers: a retrospective cohort study.
Article in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Diabetic foot ulcers (DFUs) are associated with substantial risks of infection, amputation, and death; however, conventional anatomical classification systems do not fully capture the systemic inflammatory and nutritional status that may influence prognosis. We aimed to evaluate the prognostic value of the C-reactive protein-to-albumin ratio (CAR) and to develop a nomogram for predicting 6-month major adverse limb events (MALE) in hospitalized patients with DFUs. Methods: We conducted a retrospective cohort study of patients treated at a regional referral center in Northwest China between January 2020 and January 2025. Among 321 screened patients, 139 with complete data were included in the final analysis. MALE was defined as major amputation, unplanned limb revascularization, or death related to foot deterioration or progression of sepsis. Multivariable logistic regression was used to identify independent predictors. Model performance was assessed by discrimination, calibration, bootstrap internal validation, the Brier score, integrated discrimination improvement, net reclassification improvement, and decision curve analysis. Results: During follow-up, 43 patients (31.0%) experienced MALE. CAR (adjusted odds ratio 1.22, 95% confidence interval 1.03-1.48; P = 0.033) and log-transformed ulcer area (adjusted odds ratio 2.43, 95% confidence interval 1.52-4.10; P < 0.001) were independently associated with MALE. The model including CAR achieved an area under the receiver operating characteristic curve of 0.852, compared with 0.827 for the base model, although the difference was not statistically significant by DeLong testing. Adding CAR improved the Brier score and yielded a positive integrated discrimination improvement. Bootstrap validation showed an optimism-corrected C-index of 0.831, and calibration remained acceptable. Discussion: CAR was independently associated with 6-month MALE in patients with DFUs. A nomogram incorporating CAR and conventional clinical variables demonstrated good discrimination, calibration, and internal validity, with modest incremental improvement in risk stratification. External validation is warranted before broader clinical application.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.